Total Valuation
Encompass Health has a market cap or net worth of $251.87B. The enterprise value is $15.70B.
Market Cap$251.87B
Enterprise Value$15.70B
Share Statistics
Encompass Health has 98,653,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,653,380
Owned by Insiders1.00%
Owned by Institutions4.36%
Financial Efficiency
Encompass Health’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 13.28%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)13.28%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee196.36K
Profits Per Employee18.77K
Employee Count30,226
Asset Turnover0.84
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Encompass Health is 21.0. Encompass Health’s PEG ratio is 0.78.
PE Ratio21.0
PS Ratio1.80
PB Ratio4.37
Price to FCF24.29
Price to Operating Cash Flow10.25
PEG Ratio0.78
Income Statement
In the last 12 months, Encompass Health had revenue of 5.94B and earned 566.20M in profits. Earnings per share was 5.62.
Revenue5.94B
Gross Profit2.56B
Operating Income1.05B
Pretax Income953.00M
Net Income566.20M
EBITDA1.40B
Earnings Per Share (EPS)5.62
Cash Flow
In the last 12 months, operating cash flow was 1.30B and capital expenditures -846.50M, giving a free cash flow of 457.20M billion.
Operating Cash Flow1.30B
Free Cash Flow457.20M
Free Cash Flow per Share4.63
Dividends & Yields
Encompass Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.26
52-Week Price Change8.68%
50-Day Moving Average2.10K
200-Day Moving Average1.90K
Relative Strength Index (RSI)99.75
Average Volume (3m)5.00
Important Dates
Encompass Health upcoming earnings date is Feb 11, 2027, After Close (Confirmed).
Last Earnings DateOct 28, 2026
Next Earnings DateFeb 11, 2027
Ex-Dividend Date―
Financial Position
Encompass Health as a current ratio of 1.08, with Debt / Equity ratio of 104.56%
Current Ratio1.08
Quick Ratio1.08
Debt to Market Cap0.21
Net Debt to EBITDA1.86
Interest Coverage Ratio8.55
Taxes
In the past 12 months, Encompass Health has paid 192.90M in taxes.
Income Tax192.90M
Effective Tax Rate0.20
Enterprise Valuation
Encompass Health EV to EBITDA ratio is 9.46, with an EV/FCF ratio of 30.23.
EV to Sales2.24
EV to EBITDA9.46
EV to Free Cash Flow30.23
EV to Operating Cash Flow11.29
Balance Sheet
Encompass Health has $76.20M in cash and marketable securities with $2.80B in debt, giving a net cash position of -$2.73B billion.
Cash & Marketable Securities$76.20M
Total Debt$2.80B
Net Cash-$2.73B
Net Cash Per Share-$27.64
Tangible Book Value Per Share$16.42
Margins
Gross margin is 38.53%, with operating margin of 17.74%, and net profit margin of 9.54%.
Gross Margin38.53%
Operating Margin17.74%
Pretax Margin16.06%
Net Profit Margin9.54%
EBITDA Margin23.66%
EBIT Margin18.13%
Analyst Forecast
The average price target for Encompass Health is $2,842.82, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$2,842.82
Price Target Upside48.06% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast-1.95%
EPS Growth Forecast8.13%